EAST PALO ALTO, Calif., May 04, 2018 -- In a release issued under the same headline earlier today by Finjan Holdings, Inc. (NASDAQ:FNJN), please note that in the second paragraph of the release, the filing date of the case should be May 3, not March 3 as previously stated. The corrected release follows:
Finjan Holdings, Inc. (NASDAQ:FNJN), a cybersecurity company today announced that – after numerous unsuccessful attempts to engage in productive, quality licensing discussions with Check Point – its subsidiary Finjan, Inc. (“Finjan”) has filed a patent infringement lawsuit against Check Point Software Technologies, Inc. (NASDAQ:CHKP) (“Check Point USA”) and Check Point software Technologies Ltd. (“Check Point Israel”) (collectively, “Check Point”).
The Complaint, filed in the U.S. District Court for the Northern District of California on May 3, 2018, (Case No. 5:18-cv-02621), alleges that the Check Point products listed below (“the Accused Products”) infringe at least one or more of the following Finjan patents: U.S. Patent Nos. 6,154,844, 6,965,968, 7,418,731, 7,647,633, 8,079,086, 8,141,154, 8,677,494 (collectively the “Asserted Patents”).
The Accused Products include Check Point’s: Next Generation Firewalls and Security Gateways for Cloud, Data Center, Midsized and Enterprise, Small Business, Consumer, and Home Office; CloudGuard products; Endpoint Protection products; Advanced Threat Prevention products, including with Sandblast technology, for Network Security, Endpoint Protection, and Mobile Threat Prevention; ZoneAlarm products; Threat Intelligence; ThreatCloud; Security Management products, including Smart-1 appliances; and Infinity, including R80.10.
Finjan is seeking a judgment of infringement of the Asserted Patents by the Accused Products, a preliminary and permanent injunction, past damages no less than a reasonable royalty, attorneys’ fees, pre- and post-judgment infringement, and any other relief deemed proper by the Court.
Finjan also has pending infringement lawsuits against Palo Alto Networks, ESET and its affiliates, Cisco Systems, Inc., Sonicwall, Inc., Bitdefender and its affiliates, Juniper Networks and Zscaler, Inc. relating to, collectively, more than 20 patents in the Finjan portfolio. The court dockets for the foregoing cases are publicly available on the Public Access to Court Electronic Records (PACER) website, www.pacer.gov, which is operated by the Administrative Office of the U.S. Courts.
ABOUT FINJAN
Established more than 20 years ago, Finjan is a globally recognized leader in cybersecurity. Finjan’s inventions are embedded within a strong portfolio of patents focusing on software and hardware technologies capable of proactively detecting previously unknown and emerging threats on a real-time, behavior-based basis. Finjan continues to grow through investments in innovation, strategic acquisitions, and partnerships promoting economic advancement and job creation. For more information, please visit www.finjan.com.
Follow Finjan Holdings, Inc.:
Twitter: @FinjanHoldings
LinkedIn: linkedin.com/company/finjan
Facebook: facebook.com/FinjanHoldings
Cautionary Note Regarding Forward-Looking Statements
Except for historical information, the matters set forth herein that are forward-looking statements involve certain risks and uncertainties that could cause actual results to differ. Potential risks and uncertainties include, but are not limited to, Finjan’s expectations and beliefs regarding Finjan’s licensing program, the outcome of pending or future enforcement actions, the granting of Inter Partes Review (IPR) of our patents or an unfavorable determination pursuant to an IPR or other challenges at the USPTO of our patents, the enforceability of our patents, the cost of litigation, the unpredictability of our cash flows, our ability to expand our technology and patent portfolio, the continued use of our technologies in the market, our stock price, changes in the trading market for our securities, regulatory developments, general economic and market conditions, the market acceptance and successful business, technical and economic implementation of Finjan Holdings' intended operational plan; and the other risk factors set forth from time to time in our filings with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2017, and the Company's periodic filings with the SEC, copies of which are available free of charge at the SEC's website at www.sec.gov or upon request from Finjan Holdings, Inc. All forward-looking statements herein reflect our opinions only as of the date of this release. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Finjan Holdings undertakes no obligation, and expressly disclaims any obligation, to update forward-looking statements herein in light of new information or future events.
Investor Contact:
Vanessa Winter | Director of Investor Relations, Finjan Holdings
Valter Pinto | KCSA Strategic Communications
(650) 282-3245 | [email protected]


Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
Zhipu AI Stock Jumps on Report of Custom AI Chip Development Plans
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns
SK Hynix’s $28 Billion U.S. Share Sale Draws Massive Demand Amid AI Chip Boom
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings 



